Effectiveness and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Single-centre Retrospective Study

Effectiveness and Safety of Spesolimab in Patients with Generalized Pustular Psoriasis: A Single-centre Retrospective Study

Saved in:

Bibliographic Details
Main Authors:	Yoshiki Okada, Masahiro Kamata, Kotaro Hayashi, Kazumitsu Sugiura, Yayoi Tada
Format:	Article
Language:	English
Published:	Medical Journals Sweden 2025-02-01
Series:	Acta Dermato-Venereologica
Subjects:	psoriasis generalized pustular psoriasis spesolimab interleukin-36 GPPASI JDA severity score
Online Access:	https://medicaljournalssweden.se/actadv/article/view/42879
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Crusted Scabies in a Patient being Treated with Spesolimab for Generalized Pustular Psoriasis
by: Hanna Schratter, et al.
Published: (2025-02-01)

Real-Life Analysis of Therapeutic Management and Its Correlation With the Dermatology Life Quality Index Score in 108 Patients With Pustular Psoriasis: An Italian Monocenter Study
by: Dario Buononato, et al.
Published: (2025-01-01)

Generalized pustular psoriasis: a multicentric study on patient characteristics and clinical burden
by: Cristina Bulai Livideanu, et al.
Published: (2025-02-01)

Isotretinoin – Induced AGEP: A Case Report
by: Alotaibi HM, et al.
Published: (2025-02-01)

Incidence of HBV Reactivation in Psoriasis Patients Undergoing Cytokine Inhibitor Therapy: A Single-Center Study and Systematic Review with a Meta-Analysis
by: Meng Hsuan Kuo, et al.
Published: (2024-12-01)

Aspectos psicológicos para el manejo de la psoriasis
by: Rubén Pérez Armas, et al.
Published: (2013-10-01)

Geriatric Psoriasis: Evaluation of Clinical Features, Disease Course, and Treatment Modalities of Patients from a Tertiary Care Hospital
by: Elif Çalışkan, et al.
Published: (2025-01-01)

Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis
by: Mengmeng Li, et al.
Published: (2025-02-01)

Depression and anxiety among psoriasis patients
by: Hojat Eftekhari, et al.
Published: (2024-11-01)

Portuguese consensus on first line treatment of moderate-to-severe psoriasis with a non-TNF inhibitor therapy – a delphi methodology
by: Tiago Torres, et al.
Published: (2025-12-01)

Successful treatment of etanercept- and adalimumab-resistant pyoderma gangrenosum with spesolimab, moderate-dose corticosteroids, and minocycline
by: Hanlin Zhang, et al.
Published: (2025-12-01)

Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01)

CONDITIONS OF SKIN AND INTESTINE MICROBIOTES IN PATIENTS WITH PSORIASIS
by: Ya.O. Yemchenko, et al.
Published: (2022-04-01)

Drug-induced psoriasis
by: Sunil Dogra, et al.
Published: (2019-01-01)

Cardiovascular Complications During Delivery Hospitalization in Patients With Psoriasis
by: Ankit Agrawal, MD, et al.
Published: (2025-02-01)

Intralesional Spesolimab: A Novel and Effective Approach for Palmoplantar Pustulosis Treatment – A Case Report
by: Wang SN, et al.
Published: (2025-01-01)

Managing pediatric psoriasis: update on treatments and challenges—a review
by: A. A. Hebert, et al.
Published: (2022-07-01)

Comparison of Mean Platelet Volume (MPV) in Patients with Psoriasis and Healthy Individuals
by: Komal Shehzade, et al.
Published: (2025-01-01)

Successful Treatment of Linear Psoriasis With the IL-17a-Antagonist Ixekizumab: A Case Report
by: Christov S, et al.
Published: (2025-01-01)

Assessing Psychosocial Burden in Psoriasis Patients Using the PRISM-RII Tool: A Comprehensive Evaluation
by: Elif Afacan Yıldırım, et al.
Published: (2025-01-01)

Psoriasis severity in moderate to severe psoriatic Greek patients routinely treated with systemic treatment: a cross-sectional and retrospective chart review study (CRYSTAL-Greece)
by: Dimitrios Rigopoulos, et al.
Published: (2025-12-01)

Quality of Life in Psoriasis: A Cross-Sectional Study from North India
by: Khushboo Arora, et al.
Published: (2024-01-01)

FEATURES OF THE CLINICAL COURSE OF PSORIASIS IN PATIENTS WITH OBESITY
by: Ya.O. Yemchenko, et al.
Published: (2020-04-01)

Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label, Single-Arm (aIMM) Study
by: Richard B. Warren, et al.
Published: (2024-11-01)

Catgutpuncture and ozone therapy combined treatment in vulgar psoriasis. Lucia Íñiguez Landín Clinical Surgical Hospital. 2019- 2021
by: Lisbet López Mulet, et al.
Published: (2023-05-01)

Real-life Experience of Bimekizumab in 27 Obese Patients With Plaque-type Psoriasis: a 24-week Multicenter Retrospective Study
by: Zeno Fratton, et al.
Published: (2025-01-01)

Immune links in comorbid depression and psoriasis: A narrative mini-review and perspective
by: Georgia Lada
Published: (2025-03-01)

Dermatological Disorders Associated with Pregnancy
by: Grzegorz Szcześniak, et al.
Published: (2025-02-01)

Gender-related Therapeutical Response to Apremilast: New Insights in a Tailored Management of Psoriasis
by: Emanuele Trovato, et al.
Published: (2025-01-01)

Biological therapy in the reduction of cardiovascular risk in patients with psoriasis
by: Andrés Tirado-Sánchez
Published: (2025-01-01)

Roles for Exosomes in the Pathogenesis, Drug Delivery and Therapy of Psoriasis
by: Yuchao Chen, et al.
Published: (2025-01-01)

Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study
by: Federico Diotallevi, et al.
Published: (2025-01-01)

COVID-19 pandemic and vaccination rate in patients with psoriasis treated with biologics: A single center experience
by: Milčić Danijela, et al.
Published: (2024-01-01)

Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
by: Elena Franchi, et al.
Published: (2023-12-01)

Association between the exposure to brominated flame retardants and psoriasis risk among U.S. adults: A population-based study
by: Jingbo Zhang, et al.
Published: (2025-02-01)

Causal Relationship Between Psoriasis and Bullous Pemphigoid: A Mendelian Randomization Analysis
by: Xiaoxue Wang, et al.
Published: (2025-01-01)

PEPITEM, its tripeptide pharmacophores and their peptidomimetic analogues regulate the inflammatory response through parenteral and topical dosing in models of peritonitis and psoriasis
by: Anella Saviano, et al.
Published: (2025-03-01)

Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study – IL PSO (Italian landscape psoriasis)
by: Mario Valenti, et al.
Published: (2025-12-01)

Tanshinone I Ameliorates Psoriasis-Like Dermatitis by Suppressing Inflammation and Regulating Keratinocyte Differentiation
by: Wang Q, et al.
Published: (2025-01-01)

A New Diagnosing Method for Psoriasis From Exhaled Breath
by: Bilge Han Tozlu, et al.
Published: (2025-01-01)